Orchard Therapeutics announced that Frank Thomas will step down from his role as president and chief operating officer, following a transition in 2022. A search for a chief financial officer is underway. Mr. Thomas? other responsibilities will be assumed by existing members of the leadership team in commercial and corporate affairs.